INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 414m ago
HOUSE PTR13m ago
SEC 13F13m ago
ROBINHOOD CHAIN13m ago
SEC FORM 4/Option exerciseVerified dataRule 10b5-1 plan

McNamara Peter reported TECX

Chief Scientific Officer · Tectonic Therapeutic, Inc. · Tectonic Therapeutic, Inc. — Employee Stock Option (Right to Buy)

Side
M
Value
—
Shares
215
Price
—
Executed
Mar 6, 2026
Disclosed
Mar 9, 2026
Disclosure timeline3 days from execution to publication · legal deadline 2 business days
Mar 6 executedMar 9, 2026 disclosed

TECX · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
0/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Option exercise — administrative, little informational value

  • Relative size+1 / 25

    No reported dollar value · 2.7% of prior position

  • Filing timing0 / 15

    Disclosed 1 business day after execution (deadline: 2)

  • Historical behavior+4 / 15

    2 prior trades recorded in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

  • Pre-arranged plan-10

    Executed under a Rule 10b5-1 trading plan

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · TECX

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    9
    RA
    Reicin AliseDirector, Chief Executive Officer
    TECXTectonic Therapeutic, Inc.
    Option exercise
    		M$24K
    10.0K sh
    		Oct 26, 2026Oct 28, 2026
    traded Oct 26, 2026
    		+2dSEC FORM 4

    Evidence

    21
    RA
    Reicin AliseDirector, Chief Executive Officer
    TECXTectonic Therapeutic, Inc.
    Option exercise
    		M—
    10.0K sh
    		Oct 26, 2026Oct 28, 2026
    traded Oct 26, 2026
    		+2dSEC FORM 4

    Evidence

    11
    RK
    Ruddy Marcella K.Chief Medical Officer
    TECXTectonic Therapeutic, Inc.
    Tax withholding
    		F$12K
    525 sh
    		Sep 25, 2026Oct 2, 2026
    traded Sep 25, 2026
    		+7dSEC FORM 4

    Evidence

    0
    MP
    McNamara PeterChief Scientific Officer
    TECXTectonic Therapeutic, Inc.
    Tax withholding · 10b5-1 plan
    		F$11K
    444 sh
    		Sep 25, 2026Oct 2, 2026
    traded Sep 25, 2026
    		+7dSEC FORM 4

    Evidence

    0
    MP
    McNamara PeterChief Scientific Officer
    TECXTectonic Therapeutic, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$12K
    536 sh
    		Sep 30, 2026Oct 2, 2026
    traded Sep 30, 2026
    		+2dSEC FORM 4

    Evidence

    15
    SM
    Schwabish MarcChief Business Officer
    TECXTectonic Therapeutic, Inc.
    Tax withholding
    		F$9,728
    411 sh
    		Sep 25, 2026Oct 2, 2026
    traded Sep 25, 2026
    		+7dSEC FORM 4

    Evidence

    11
    RK
    Ruddy Marcella K.Chief Medical Officer
    TECXTectonic Therapeutic, Inc.
    Grant or award
    		A—
    24.3K sh
    		Sep 3, 2026Sep 8, 2026
    traded Sep 3, 2026
    		+5dSEC FORM 4

    Evidence

    15
    LD
    Lochner DanielChief Financial Officer
    TECXTectonic Therapeutic, Inc.
    Grant or award
    		A—
    24.3K sh
    		Sep 3, 2026Sep 8, 2026
    traded Sep 3, 2026
    		+5dSEC FORM 4

    Evidence

    15
    SM
    Schwabish MarcChief Business Officer
    TECXTectonic Therapeutic, Inc.
    Grant or award
    		A—
    17.8K sh
    		Sep 3, 2026Sep 8, 2026
    traded Sep 3, 2026
    		+5dSEC FORM 4

    Evidence

    8
    MP
    McNamara PeterChief Scientific Officer
    TECXTectonic Therapeutic, Inc.
    Grant or award
    		A—
    21.0K sh
    		Sep 3, 2026Sep 8, 2026
    traded Sep 3, 2026
    		+5dSEC FORM 4

    Evidence

    0
    MP
    McNamara PeterChief Scientific Officer
    TECXTectonic Therapeutic, Inc.
    Option exercise · 10b5-1 plan
    		M—
    43 sh
    		Aug 25, 2026Aug 26, 2026
    traded Aug 25, 2026
    		+1dSEC FORM 4

    Evidence

    0
    MP
    McNamara PeterChief Scientific Officer
    TECXTectonic Therapeutic, Inc.
    Option exercise · 10b5-1 plan
    		M$633
    43 sh
    		Aug 25, 2026Aug 26, 2026
    traded Aug 25, 2026
    		+1dSEC FORM 4

    Evidence

    0
    MP
    McNamara PeterChief Scientific Officer
    TECXTectonic Therapeutic, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$1,570
    43 sh
    		Aug 25, 2026Aug 26, 2026
    traded Aug 25, 2026
    		+1dSEC FORM 4

    Evidence

    1
    MP
    McNamara PeterChief Scientific Officer
    TECXTectonic Therapeutic, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$1,505
    43 sh
    		Aug 12, 2026Aug 14, 2026
    traded Aug 12, 2026
    		+2dSEC FORM 4

    Evidence

    0
    MP
    McNamara PeterChief Scientific Officer
    TECXTectonic Therapeutic, Inc.
    Option exercise · 10b5-1 plan
    		M$633
    43 sh
    		Aug 12, 2026Aug 14, 2026
    traded Aug 12, 2026
    		+2dSEC FORM 4

    Evidence

    0
    MP
    McNamara PeterChief Scientific Officer
    TECXTectonic Therapeutic, Inc.
    Option exercise · 10b5-1 plan
    		M—
    43 sh
    		Aug 12, 2026Aug 14, 2026
    traded Aug 12, 2026
    		+2dSEC FORM 4

    Evidence

    1
    MP
    McNamara PeterChief Scientific Officer
    TECXTectonic Therapeutic, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$6,020
    172 sh
    		Jun 30, 2026Jul 1, 2026
    traded Jun 30, 2026
    		+1dSEC FORM 4

    Evidence

    0
    MP
    McNamara PeterChief Scientific Officer
    TECXTectonic Therapeutic, Inc.
    Option exercise · 10b5-1 plan
    		M$2,530
    172 sh
    		Jun 30, 2026Jul 1, 2026
    traded Jun 30, 2026
    		+1dSEC FORM 4

    Evidence

    0
    MP
    McNamara PeterChief Scientific Officer
    TECXTectonic Therapeutic, Inc.
    Option exercise · 10b5-1 plan
    		M—
    172 sh
    		Jun 30, 2026Jul 1, 2026
    traded Jun 30, 2026
    		+1dSEC FORM 4

    Evidence

    9
    VS
    Vitorovic StefanDirector
    TECXTectonic Therapeutic, Inc.
    Grant or award
    		A—
    10.2K sh
    		Jun 9, 2026Jun 10, 2026
    traded Jun 9, 2026
    		+1dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0002023255-26-000005
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Mar 6, 2026
    Published
    Mar 9, 2026
    Ingested by INSIDER
    Nov 5, 04:12 UTC
    Last re-read
    Nov 5, 04:12 UTC

    Extracted facts

    Filer
    McNamara Peter
    Role
    Chief Scientific Officer
    Transaction
    Option exerciseAs filed: “M”
    Asset
    Tectonic Therapeutic, Inc. — Employee Stock Option (Right to Buy)
    Ticker
    TECX
    Shares
    215
    Price per share
    $0
    Execution date (reported)
    Mar 6, 2026
    Owned after transaction
    8,045 shares
    Rule 10b5-1 plan
    Yes, as checked by the filer
    Days from execution to publication
    3

    What this establishes

    McNamara Peter filed this Form 4 reporting a option exercise of TECX on Mar 6, 2026. It became public on Mar 9, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Chief Scientific Officer
    McNamara Petercik:0002023255
    Issuer
    Tectonic Therapeutic, Inc.cik:0001681087

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.